Skip to content
Menu

Alvotech ALVO

Full chart Compare
Set alert

Price alert · ALVO

All alert types
4.12 USD -0.17 (-3.96%)

Regular-session close

4.12 0.00 0.00%

After hours · Nov 20, 4:01 PM ET

4.09 Day range 4.29
2.94 52-week range 6.53
YTD
-19.69%
1 year
-18.58%

Fundamental scorecard

5 of 25 checks passed on ALVO’s reported financials

ValueGrowthProfitabilityHealthDividend

5of 25 checks passed

  • Value 1 of 5
  • Growth 2 of 5
  • Profitability 1 of 5
  • Financial health 1 of 5
  • Dividend No data

Statements to Jun 30, 2026.

Value 1 of 5

  • Failed:P/E below its own 5-year median No profit over the last 12 months, so no P/E.
  • Failed:P/E under 20 No profit over the last 12 months, so no P/E.
  • Passed:Price to sales below its own 5-year median Price to sales 3.0 against a 5-year median of 7.8.
  • Failed:Price to book below its own 5-year median Shareholders’ equity is negative.
  • Failed:Free cash flow yield above 4% Free cash flow of -140M is -9.5% of the market value.

Growth 2 of 5

  • Failed:Revenue grew over the last year Revenue of 495M is -12.1% on the 12 months before.
  • Passed:Revenue grew more than 5% a year over five years +53.3% a year from FY 2020 to FY 2025.
  • Failed:Earnings per share grew over the last year EPS -0.61 against 0.23 in the 12 months before.
  • Passed:Earnings per share grew more than 5% a year over five years EPS -1.82 in FY 2020, 0.10 in FY 2025.
  • No data:Analysts expect higher earnings per share over the next year No analyst estimate.

Profitability 1 of 5

  • Failed:Profitable over the last year Net income of -180M over the last 12 months.
  • Failed:Profitable in each of the last five fiscal years A profit in 1 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Shareholders’ equity is negative.
  • Passed:Net margin above its 5-year average Net margin of -36.3% against a 5-year average of -298.6%.
  • Failed:Free cash flow is at least 80% of net income No profit over the last 12 months to compare with.

Financial health 1 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 545M against short-term liabilities of 331M.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 545M against long-term liabilities of 1.45B.
  • Failed:Net debt under 40% of equity Shareholders’ equity is negative.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of -77.2M is -5.3% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is 0.8 times the interest expense.

Dividend No data

  • No data:Pays a dividend Not enough data to decide.
  • No data:Yield above 1.5% Not enough data to decide.
  • No data:Pays out under 75% of profit Not enough data to decide.
  • No data:Covered by free cash flow Not enough data to decide.
  • No data:Not cut in the last five fiscal years Not enough data to decide.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What ALVO owns and owes, as of Jun 30, 2026

Short term and long term

Balance sheet · 1.59B of assets

Liabilities exceed assets, so there is no shareholders’ equity to show.

Debt, equity and cash by year

Now: 1.31B of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

-1.34 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 51.3×
P/S 2.4×
P/B -5.0×
P/FCF -12.5×
EV/EBITDA 8.4×
EV/Sales 4.6×
FCF Yield -8.0%

Profitability

Gross Margin 59.8%
Operating Margin 13.3%
Net Margin 4.8%
ROE -9.8%
ROIC 1.3%
ROA 1.9%

Growth (YoY)

Revenue 19.7%
Operating Income 12.3%
EPS (diluted) 111.5%
Free Cash Flow 61.0%

Financial Health

Current Ratio 1.9×
Quick Ratio 1.2×
Debt / Equity -5.1×
Net Debt / EBITDA 3.9×
Interest Coverage 0.5×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31